Table 2.
Model Estimates (Standard Errors) of MetS Prevalence | ||||||||
Overall | Age < 50 | Age 50 – < 60 | Age ≥60 | |||||
Visit 1 Rate | Ratio* | Visit 1 Rate | Ratio* | Visit 1 Rate | Ratio* | Visit 1 Rate | Ratio* | |
White Males | 0.38 (0.01) | 1.10 (0.01) | 0.33 (0.01) | 1.14 (0.02) | 0.38 (0.01) | 1.10 (0.01) | 0.42 (0.02) | 1.07 (0.01) |
White Females | 0.30 (0.01)a | 1.17 (0.01)a | 0.21 (0.01)a | 1.23 (0.02)a | 0.32 (0.01)a | 1.17 (0.01)a | 0.40 (0.02) | 1.10 (0.01) |
AA Males | 0.30 (0.02)a | 1.10 (0.02)b | 0.30 (0.03)b | 1.11 (0.03)b | 0.30 (0.02)a | 1.10 (0.03)b | 0.31 (0.04)ab | 1.07 (0.05) |
AA Females | 0.43 (0.01)abc | 1.12 (0.01)b | 0.35 (0.02)b | 1.18 (0.02) | 0.47 (0.02)abc | 1.10 (0.02)b | 0.49 (0.03)bc | 1.06 (0.03) |
Model Estimates (Standard Errors) of MetS Severity | ||||||||
Overall | Age < 50 | Age 50 – < 60 | Age ≥60 | |||||
Visit 1 Mean | Difference** | Visit 1 Mean | Difference** | Visit 1 Mean | Difference** | Difference** | Difference** | |
White Males | 0.30 (0.01) | 0.07 (0.00) | 0.30 (0.03) | 0.09 (0.01) | 0.30 (0.02) | 0.07 (0.01) | 0.33 (0.03) | 0.05 (0.01) |
White Females | −0.08 (0.01)a | 0.16 (0.00)a | −0.30 (0.02)a | 0.18 (0.01)a | −0.03 (0.02)a | 0.16 (0.01)a | 0.13 (0.03)a | 0.12 (0.01)a |
AA Males | 0.02 (0.03)ab | 0.11 (0.02)ab | −0.03 (0.06)ab | 0.16 (0.04) | −0.02 (0.04)a | 0.11 (0.02)b | 0.10 (0.07)a | 0.03 (0.02)b |
AA Females | 0.21 (0.03)abc | 0.18 (0.01)ac | 0.06 (0.05)ab | 0.23 (0.03)a | 0.26 (0.04)bc | 0.17 (0.02)ac | 0.38 (0.06)bc | 0.10 (0.02)ac |
Ratio = Multiplicative increase in MetS rate between any two successive visits (bold indicates different than 1 (p < 0.05))
Difference = Additive increase in mean MetS severity between any two visits (bold indicates different than 0 (p < 0.05))
Statistical comparisons (white male as referent):
Different than white male (p < 0.05)
Different than white female (p < 0.05)
Different than African-American male (p < 0.05)